CLINICAL_TRIALS
trial_result
· 2026-03-30
Clinical Trial Update: Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis [Phase 2]
Summary
Phase 2 trial of LNA043 for knee osteoarthritis was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Osteoarthritis | Phase 2 | Status: TERMINATED | Results posted: 2026-03-30